Earnings Call Presentation 9M/2023

08 November 2023

01 _ Overview

Page 02

02 _ Key Figures 9M/2023 03 _ Outlook 2023 04 _ Appendix

AGENDA

Highlights 9-month period 2023

01 Significant progress in profitability in Q3 with an operating EBIT margin of 16.2% (previous year: 13.8%) 05 Double-digit earnings target sustainably achieved with

EBIT margin of 14.0% (previous year: 13.7%)

02 Positive development reflects successful turnaround of subsidiary APT, implemented price adjustments and further cost optimisations 06 Stable liquidity situation despite strategic

working capital build-up - high cash position at EUR 9.6 million

03 High demand momentum in the aviation business and the life science and medical technology sectors 07

04 Broad diversification is reflected in stable revenue development

Robust order situation - incoming orders remain at a satisfactory normal level

02 Key Figures

Key Figures (1) 9M/2023

§ Revenue increase of 3.8% in 9M/2023 compared to prior-year period

§ Group operating EBIT up 6.1% than the prior-year period

§ Operating EBIT margin rises to 14.0% after nine months (9M/2022: 13.7%)

§ Significant margin increase in Q3 with 16.2% operating EBIT margin (previous year: 13.8%)

Significant progress in profitability in Q3 and solid nine months of 2023

In EUR million	9M/2023	9M/2022	Change
Revenue	79.0	76.0	+3.8%
EBITDA	14.7	14.1	+4.6%
EBIT (operating)	11.0	10.4	+6.1%
Group result	7.2	7.3	-1.3%
EPS (in EUR)	0.75	0.76	-1.3%

Rising group equity in the 9-month period

Page 07

§ Consolidated equity increases to EUR 57.4 million as of 30 September 2023 (31 December 2022: EUR 52.0 million) due to positive earnings situation
§ Cash and cash equivalents almost unchanged at EUR 9.6 million as of 30 September 2023 (31 December 2022: EUR 9.7 million) reflects working capital build-up and dividend increase
§ Operating cashflow in 9M/2023 at EUR 7.6 million (9M/2022: EUR 5.7 million) – despite growth-related increase in working capital

Equity increased further

Group equity and equity ratio in EUR million

30,0

34,0

38,0

42,0

46,0

50,0

54,0

58,0

62,0

Outlook 2023

Positive price effects due to subsequent price adjustments with a corresponding effect on revenue and results

Stable growth in business thanks to broad industry expertise

Continuous and sustainable implementation of further measures to increase efficiency

For 2023: continued growth in revenue to EUR 103 million to EUR 110 million expected (2022: EUR 100.3 million)

Operating EBIT to increase to between EUR 11 million and EUR 14 million in 2023 (2022: EUR 11.4 million) - Stabilisation and further expansion of the yield level achieved

Recessionary trends in traditional customer industries are (over)compensated by medical technology, life-science, semiconductor technology and aviation

Solid order backlog and robust order intake

Forecast for 2023 confirmed despite economic, interest rate and geopolitical uncertainties confirmed

Masterflex at a glance

in thousand EUR	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	9M/2023
Revenue	77,243	79,969	71,881	79,068	100,274	78,967
EBITDA	9,592	9,656	7,892	10,670	16,436	14,729
EBIT (operating)	6,251	5,058	3,167	5,764	11,395	11,043
Group result	3,373	2,532	793	3,282	7,777	7,240
EPS (in Euro)	0.35	0.26	0.08	0.34	0.81	0.75

Contact Investor Relations

Page 12

Address

Masterflex SE Mark Becks, CFO Willy-Brandt-Allee 300 45891 Gelsenkirchen

CROSS ALLIANCE communication GmbH Susan Hoffmeister Bahnhofstraße 98 82166 Graefelfing/Munich Phone

Phone.: +49 209 97077 0 Fax: +49 209 97077 33

Tel.: +49 89 125 09 03 33

Online

[email protected] [email protected]

AI assistant